Literature DB >> 11229476

Molecular and cellular mediators of interleukin-1-dependent acute inflammatory arthritis.

K E Lawlor1, I K Campbell, K O'Donnell, L Wu, I P Wicks.   

Abstract

OBJECTIVE: To examine the molecular and cellular mechanisms in a model of acute inflammatory monarticular arthritis induced by methylated bovine serum albumin (mBSA) and interleukin-1 (IL-1).
METHODS: Mice were injected intraarticularly with mBSA on day 0 and subcutaneously with recombinant human IL-1beta on days 0-2. At day 7, knee joints were removed and assessed histologically. Flow cytometry and RNase protection were used to analyze IL-1-dependent events.
RESULTS: C57BL/6 (B6), 129/Sv, and (B6 x 129/ Sv)F1 hybrid mice, all H-2b strains, were susceptible to mBSA/IL-1-induced arthritis, whereas C3H/HeJ (H-2k) mice were not. B6 mice lacking T and B cells (RAG1-/-) or major histocompatibility complex (MHC) class II antigens (MHCII-/-), and B6 mice treated with a CD4+ T cell-depleting monoclonal antibody, were resistant to disease. In contrast, B cell-deficient (muMT/ muMT) mice developed arthritis at an incidence and severity similar to that of controls. RelB-deficient (RelB-/-) bone marrow chimeric mice had arthritis that was significantly reduced in incidence and severity. In B6 mice, flow cytometry demonstrated an IL-1-dependent leukocyte infiltration into the synovial compartment and RNase protection assays revealed induction of messenger RNA (mRNA) for the chemokines monocyte chemoattractant protein 1, macrophage inhibitory protein 2 (MIP-2), RANTES, MIP-1alpha, and MIP-1beta, in vivo and in vitro.
CONCLUSION: Arthritis induced by mBSA/IL-1 is strain specific and dependent on CD4+ T lymphocytes and at least partially on RelB, but not on B lymphocytes or antibody. IL-1 contributes to leukocyte recruitment to the synovium and directly induces chemokine mRNA production by synovial cells. This model of acute monarticular arthritis is particularly suitable for further investigations into cell-mediated immunity in arthritis and the role of IL-1.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11229476     DOI: 10.1002/1529-0131(200102)44:2<442::AID-ANR63>3.0.CO;2-M

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  21 in total

1.  Vascular cell adhesion molecule-1 (VCAM-1) blockade in collagen-induced arthritis reduces joint involvement and alters B cell trafficking.

Authors:  R A Carter; I K Campbell; K L O'Donnel; I P Wicks
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

Review 2.  Role of nuclear factor kappaB in synovial inflammation.

Authors:  Ulf Müller-Ladner; Renate E Gay; Steffen Gay
Journal:  Curr Rheumatol Rep       Date:  2002-06       Impact factor: 4.592

3.  Severe inflammatory arthritis and lymphadenopathy in the absence of TNF.

Authors:  I K Campbell; K O'Donnell; K E Lawlor; I P Wicks
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

4.  Augmented LPS responsiveness in type 1 diabetes-derived osteoclasts.

Authors:  Dana L Catalfamo; Nadia L Calderon; Scott W Harden; Heather L Sorenson; Kathleen G Neiva; Shannon M Wallet
Journal:  J Cell Physiol       Date:  2013-02       Impact factor: 6.384

5.  TNF and granulocyte macrophage-colony stimulating factor interdependence mediates inflammation via CCL17.

Authors:  Andrew D Cook; Ming-Chin Lee; Reem Saleh; Hsu-Wei Khiew; Anne D Christensen; Adrian Achuthan; Andrew J Fleetwood; Derek C Lacey; Julia E Smith; Irmgard Förster; John A Hamilton
Journal:  JCI Insight       Date:  2018-03-22

6.  Critical role for granulocyte colony-stimulating factor in inflammatory arthritis.

Authors:  Kate E Lawlor; Ian K Campbell; Donald Metcalf; Kristy O'Donnell; Annemarie van Nieuwenhuijze; Andrew W Roberts; Ian P Wicks
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-22       Impact factor: 11.205

7.  The SOCS box of suppressor of cytokine signaling-3 contributes to the control of G-CSF responsiveness in vivo.

Authors:  Kristy Boyle; Paul Egan; Steven Rakar; Tracy A Willson; Ian P Wicks; Donald Metcalf; Douglas J Hilton; Nicos A Nicola; Warren S Alexander; Andrew W Roberts; Lorraine Robb
Journal:  Blood       Date:  2007-05-17       Impact factor: 22.113

Review 8.  Targeting GM-CSF in inflammatory diseases.

Authors:  Ian P Wicks; Andrew W Roberts
Journal:  Nat Rev Rheumatol       Date:  2015-12-03       Impact factor: 20.543

9.  Imbalanced gp130-dependent signaling in macrophages alters macrophage colony-stimulating factor responsiveness via regulation of c-fms expression.

Authors:  Brendan J Jenkins; Dianne Grail; Melissa Inglese; Cathy Quilici; Steven Bozinovski; Peter Wong; Matthias Ernst
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

10.  Suppressor of cytokine signaling-1 regulates acute inflammatory arthritis and T cell activation.

Authors:  Paul J Egan; Kate E Lawlor; Warren S Alexander; Ian P Wicks
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.